Dr. Claus Braestrup
Dr. Claus Braestrup has joined the Board of Directors at Swedish firm Gyros AB.
Previously President and CEO at Lundbeck, Braestrup comes from a wealth of high-end jobs including roles at Novo Nordisk and Schering.
CEO at Gyros, Erik Walldén said: “His excellent scientific background and many years’ experience within the biotech and pharmaceutical industry will be a great asset to Gyros.”